Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.
Miao YuDorothea Terhorst-MolawiSabine AltrichterTomasz HawroYu-Di ChenBo LiuXiao-Ting SongZuo-Tao ZhaoMarcus MaurerPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)
Keyphrases